查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1950443

膠囊式胃腸內視鏡設備市場：按技術、產品、功能、應用和最終用戶分類，全球預測（2026-2032年）

Capsule Gastrointestinal Endoscopic Devices Market by Technology, Product, Feature, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，膠囊內視鏡市場價值將達到 10.2 億美元，到 2026 年將成長至 11.4 億美元，到 2032 年將達到 24.8 億美元，複合年成長率為 13.44%。

關鍵市場統計數據
基準年 2025 10.2億美元
預計年份：2026年 11.4億美元
預測年份 2032 24.8億美元
複合年成長率 (%) 13.44%

權威解讀膠囊內視鏡：聚焦臨床獲益、技術基礎及影響其應用普及的營運因素

膠囊內視鏡技術融合了微創診斷技術、感測器小型化和數位化臨床工作流程。這些設備旨在胃腸道內採集內部影像和生理指標，徹底改變了臨床醫生檢測、監測和分診胃腸道疾病的方式。該技術的吸引力在於其以患者為中心的優勢，包括降低手術創傷、在某些適應症中比傳統內視鏡檢查具有更高的耐受性，以及能夠到達通常難以觀察的遠端小腸區域。

概述正在重新定義胃腸病學護理設備設計、連接選項和診斷能力的關鍵技術和臨床轉折點。

膠囊內視鏡領域近期發生的變革性變化反映了感測器性能、連接性和臨床證據生成方面多項技術的進步。高清光學技術和最佳化的照明提高了成像精度，從而能夠清晰地顯示黏膜細節和細微病變。同時，整合感測技術（例如pH值和壓力遙測）的進步，拓展了診斷能力，使其不再局限於成像，不僅可以用於病變檢測，還可以對胃動力障礙和酸暴露進行多模態評估。

評估 2025 年美國關稅如何促使醫療設備製造商和整個醫療保健系統重組其供應鏈、使其來​​源多元化並轉變籌資策略。

美國於2025年加徵關稅，導致部分進口零件和成品膠囊的供應鏈出現特定摩擦，並推高了到岸成本，促使整個價值鏈即時做出回應。醫療設備製造商和零件供應商調整了籌資策略，加快了對替代供應商的資格認證，並增加了庫存緩衝，以緩解短期生產中斷的影響。這些調整旨在維持生產的連續性，同時限制可能對醫院系統和門診醫療機構採購預算帶來額外壓力的成本。

透過整合臨床應用、終端使用者工作流程、技術選擇、產品生命週期模型和基於感測器的差異化因素的綜合細分分析，戰術性調整。

對細分市場的深入理解對於使產品開發和商業化策略與臨床應用案例和買家需求相匹配至關重要。應用細分區分了不同的診斷重點，例如：主要針對結腸息肉檢測和結直腸癌篩檢的結直腸適應症；包括巴瑞特氏食道症監測和胃食道逆流症評估在內的食道適應症；以及旨在評估乳糜瀉、監測克隆氏症和調查不明原因消化道出血適應症。這些不同的臨床路徑對影像解析度、傳輸控制和輔助感測技術提出了不同的要求。

美洲、歐洲、中東和非洲以及亞太地區的區域競爭格局和臨床實際情況將決定產品推廣路徑、監管策略和分銷重點。

各地區的趨勢反映了不同的臨床基礎設施、監管體系和報銷環境，這些因素影響著醫療器材的採用模式和策略重點。在美洲，臨床實務通常強調醫院系統和門診中心的高效手術量，而支付方的參與決定了哪些診斷路徑得以實施。因此，製造商優先考慮與現有內視鏡檢查室的整合、高效的影像審查工作流程以及支持其參與臨床試驗和指南制定的夥伴關係。

競爭格局分析，重點在於技術差異化、供應鏈穩健性、監管策略、智慧財產權定位以及服務導向型商業化模式。

膠囊內視鏡生態系統的競爭動態由成熟的醫療設備公司、專業影像Start-Ups和組件供應商共同構成，這些企業共同決定著創新速度和商業性化進程。領先的技術供應商透過投資高解析度光學元件、內建分析技術和多模態感測技術來實現差異化，從而實現病灶檢測和生理評估。同時，與臨床研究中心和醫療系統的策略合作也為實證醫學研究提供支持，推動指引的採納並影響醫保覆蓋決策。

切實可行的策略性舉措，整合證據產生、供應鏈強化、客製化商業化和夥伴關係模式，以加速臨床應用和設備永續性。

產業領導者應優先考慮將產品創新與臨床效用、營運可行性和監管準備相結合的整合策略。首先，直接投資於比較膠囊診斷與標準治療程序的臨床證據，將有助於明確應用場景，並為與支付者的對話提供支援。同時，製造商應完善產品藍圖，整合多模態感測和智慧預篩檢演算法，以縮短臨床醫師的審核時間，並提高診斷效率。

採用穩健的混合調查方法，結合專家訪談、法規和技術檢驗以及迭代三角驗證，以確保研究結果的可靠性和可操作性。

本分析的研究以對臨床醫生、採購人員、監管專家和行業高管的定性訪談為主要數據來源，並輔以對醫療設備規格、監管指南和同行評審的臨床文獻的系統性二手研究。主要數據透過結構化訪談和諮詢小組收集，旨在了解臨床工作流程、器械性能預期和採購因素等方面的現場觀點。

整合技術進步、營運重點和政策影響，以確定將創新轉化為臨床效用的策略要務。

膠囊內視鏡設備在現代診斷流程中發揮著至關重要的作用，它能夠以微創方式獲取整個胃腸道的黏膜表面和生理指標。儘管成像技術、感測器整合和連接性方面的技術進步不斷拓展其臨床效用，但操作方面的考量和區域趨勢仍影響著設備在臨床領域的應用。可重複使用和一次性產品理念、有線和無線架構以及差異化功能集之間的相互作用，造就了一個多元化的競爭環境，在這個環境中，臨床證據、供應鏈韌性和靈活的商業化模式越來越受到重視。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依技術分類的膠囊式胃腸內視鏡設備市場

  • 繫繩類型
    • 光纖
    • 有線連接
  • 無線的
    • Bluetooth
    • 射頻

第9章 膠囊式胃腸內視鏡設備市場（依產品分類）

  • 可重複使用的
    • 多用途膠囊
    • 再生膠囊
  • 一次性使用型
    • 可生物分解膠囊
    • 塑膠膠囊

第10章 膠囊式胃腸內視鏡設備市場依功能分類

  • 僅影像擷取
    • 高畫質
    • 標準解析度
  • pH感測器
    • 緩釋
    • 標準pH值
  • 壓力感測器
    • 多通道
    • 單通道

第11章 依應用分類的膠囊式胃腸內視鏡設備市場

  • 冒號
    • 結腸息肉
    • 大腸癌篩檢
  • 食道
    • 巴瑞特氏食道症
    • 胃食道逆流症
  • 小腸
    • 乳糜瀉
    • 克隆氏症
    • 不明原因的消化道出血

第12章 依最終用戶分類的膠囊式胃腸內視鏡設備市場

  • 門診手術中心
  • 診所
  • 醫院

第13章：膠囊式胃腸內視鏡設備市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 膠囊式胃腸內視鏡設備市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國膠囊式胃腸內視鏡設備市場概況

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國膠囊內視鏡設備市場

第17章：中國膠囊式胃腸內視鏡設備市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AnX Robotica Ltd.
  • Beijing Richen-Force Technology Co., Ltd.
  • Boston Scientific Corporation
  • CapsoVision, Inc.
  • Chongqing Aohua Photoelectricity Endoscope Co., Ltd.
  • Chongqing Jinshan Science & Technology Co., Ltd.
  • Given Imaging Ltd.
  • IntroMedic Co., Ltd.
  • Medtronic plc
  • Micro-Tech（Nanjing）Co., Ltd.
  • Nanjing Micro-Invasive Medical Inc.
  • Pentax Medical
  • Shanghai ANKON Medical Technologies Co., Ltd.
  • Shanghai United Imaging Healthcare Co., Ltd.
  • Shangxian Minimal Invasive Inc.
  • Shenzhen Anke High-tech Co., Ltd.
  • Shenzhen Capsule Medical Technology Co., Ltd.
  • Shenzhen Chongqing Science & Technology Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Smart Medical Systems Ltd.
  • SynMed Medical Technology Co., Ltd.
Product Code: MRR-4F7A6D4FD869

The Capsule Gastrointestinal Endoscopic Devices Market was valued at USD 1.02 billion in 2025 and is projected to grow to USD 1.14 billion in 2026, with a CAGR of 13.44%, reaching USD 2.48 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.02 billion
Estimated Year [2026] USD 1.14 billion
Forecast Year [2032] USD 2.48 billion
CAGR (%) 13.44%

An authoritative orientation to capsule gastrointestinal endoscopic devices highlighting clinical advantages, technological enablers, and operational factors shaping adoption

The landscape of capsule gastrointestinal endoscopic devices occupies an intersection of minimally invasive diagnostics, sensor miniaturization, and digitally enabled clinical workflows. These devices, designed to traverse the alimentary canal and capture internal imagery and physiological metrics, have reshaped how clinicians detect, monitor, and triage gastrointestinal conditions. The technology's appeal rests in its patient-centric advantages: reduced procedural invasiveness, improved tolerance compared with conventional endoscopy for selected indications, and the potential to reach distal small bowel segments that are otherwise challenging to visualize.

Within this clinical and commercial context, device innovation is driven by improvements in imaging resolution, extended battery life, integrated pH and pressure sensing, and innovations in data transmission that reduce the burden of tethering while preserving reliability. At the same time, clinical adoption is moderated by comparative effectiveness evidence, reimbursement pathways, and the operational preferences of end users ranging from ambulatory surgical centers to hospital-based gastroenterology units and community clinics. Consequently, stakeholders must balance clinical utility, workflow integration, cost of ownership, and environmental considerations when evaluating prospective device adoption.

This introduction frames subsequent sections by emphasizing the interplay between technology advances, clinical requirements across different gastrointestinal segments, and the strategic imperatives that device makers and health systems must navigate to translate engineering progress into sustained clinical impact.

Profiling major technological and clinical inflection points that are redefining device design, connectivity choices, and diagnostic capabilities across gastrointestinal care

Recent transformative shifts in the capsule endoscopy domain reflect converging advances in sensor capabilities, connectivity modalities, and clinical evidence generation. Imaging fidelity has improved through higher definition optics and optimized illumination, enabling more consistent visualization of mucosal detail and subtle lesions. Parallel progress in integrated sensing-such as pH and pressure telemetry-has expanded the devices' diagnostic scope beyond imaging alone, supporting multimodal assessment of motility disorders and acid exposure in addition to lesion detection.

Connectivity has bifurcated the product landscape into tethered and wireless approaches, each carrying distinct implications for procedure logistics and data management. Tethered solutions leverage reliable wired or fiber-optic links for continuous power and data throughput, while wireless approaches-including Bluetooth and radio frequency implementations-prioritize patient comfort and ambulatory monitoring. Sensor fusion, edge data processing, and on-device algorithms are reducing the downstream analyst burden by flagging frames of interest and summarizing physiologic indices for clinician review.

Concurrently, product strategies are evolving to incorporate both reusable and single-use form factors, with biodegradable materials and refurbishment models addressing environmental and cost considerations. These shifts, coupled with rising clinician familiarity and incremental guideline endorsements, are recalibrating how diagnostics are deployed across care settings and how manufacturers prioritize R&D pathways and go-to-market partnerships.

Assessing how the 2025 United States tariff measures catalyzed supply chain reconfiguration, sourcing diversification, and procurement strategy shifts across device manufacturers and health systems

The imposition of United States tariffs in 2025 introduced tangible supply-chain friction and elevated landed costs for certain imported components and finished capsules, prompting immediate operational responses across the value chain. Device manufacturers and component suppliers reassessed sourcing strategies, accelerated qualification of alternative vendors, and increased inventory buffers to mitigate near-term production interruptions. These adaptations aimed to preserve production continuity while controlling incremental cost pressures that could otherwise burden procurement budgets in hospital systems and ambulatory providers.

Beyond sourcing, the tariff environment has stimulated a deeper evaluation of localization and nearshoring as part of resilience planning. Where feasible, manufacturers prioritized domestic or regional manufacturing lines for critical subassemblies, balancing the upfront capital and regulatory harmonization requirements against the strategic benefits of supply security and reduced cross-border volatility. Regulatory submissions and quality management systems were also reviewed to ensure that any shifts in supplier base maintained compliance with relevant device standards and post-market surveillance obligations.

Clinically, procurement teams and health systems responded by optimizing purchase timing, negotiating longer-term agreements with suppliers, and increasing emphasis on total cost of ownership analyses that incorporate consumable profiles, refurbishment options, and device longevity. Taken together, the tariff-driven dynamics of 2025 catalyzed structural changes in supplier relationships, inventory policies, and manufacturing footprints, and emphasized the strategic importance of supply-chain agility for maintaining uninterrupted clinical access to capsule endoscopy capabilities.

Comprehensive segmentation insights that reconcile clinical applications, end-user workflows, technology choices, product lifecycle models, and sensor-based differentiators for tactical alignment

A nuanced understanding of segmentation is essential to align product development and commercialization strategies with clinical use cases and purchaser needs. Application segmentation differentiates diagnostic focus across colon indications-where colon polyp detection and colorectal cancer screening are primary objectives-from esophageal applications, which include Barrett's esophagus surveillance and gastroesophageal reflux disease assessments, and from small intestine uses that target celiac disease evaluation, Crohn's disease monitoring, and investigations of obscure gastrointestinal bleeding. These distinct clinical pathways drive divergent requirements for imaging resolution, transit control, and adjunctive sensing modalities.

End-user segmentation separates adoption dynamics across ambulatory surgical centers, clinics, and hospitals, each of which exhibits unique procedural workflows, reimbursement interactions, and capital budgeting cycles. Technology segmentation distinguishes tethered systems, further subdivided by fiber optic or wired link implementations that emphasize reliability and continuous power, from wireless solutions that employ Bluetooth or radio frequency channels to enable ambulatory monitoring and enhance patient comfort. Product segmentation contrasts reusable platforms, including multiuse and refurbished capsules that emphasize lifecycle economics, with single-use alternatives such as biodegradable and plastic capsules that prioritize infection control and simplified logistics.

Feature-level segmentation highlights differences among imaging-only devices available in high definition or standard definition, pH sensor offerings with extended-release or standard pH sensing profiles, and pressure sensor designs that vary between multi-channel and single-channel architectures. By integrating these segmentation lenses, stakeholders can better target clinical evidence generation, prioritize technical investments, and tailor market access approaches to the nuanced needs of each clinical and commercial cohort.

Regional competitive and clinical realities across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine adoption pathways, regulatory strategy, and distribution priorities

Regional dynamics reflect distinct clinical infrastructures, regulatory regimes, and reimbursement environments that influence device adoption patterns and strategic priorities. In the Americas, clinical practice often emphasizes high procedural throughput in hospital systems and ambulatory centers, and payor interactions shape which diagnostic pathways are operationalized. Consequently, manufacturers prioritize integration with existing endoscopy suites, efficient image review workflows, and partnerships that support clinical trials and guideline inclusion.

In Europe, the Middle East & Africa, fragmented regulatory frameworks and varied healthcare financing models necessitate regionally tailored market access strategies that balance centralized approvals with local clinical evidence generation. Clinical champions and academic centers frequently play an outsized role in demonstrating comparative clinical value, and procurement decisions may hinge on centralized tenders or national-level reimbursement policies. In Asia-Pacific, a combination of rapid technology adoption in urban centers and the need to address large rural populations drives interest in ambulatory-friendly and wireless solutions that reduce the burden on endoscopy resources and expand access to distal small bowel diagnostics.

Across all regions, companies that align manufacturing footprint, regulatory submissions, and clinical partnership strategies with local care delivery realities are better positioned to navigate reimbursement pathways, support training programs, and accelerate clinician adoption. Moreover, regional supply-chain resilience and logistics planning remain pivotal to ensure uninterrupted device availability and to support timely post-market surveillance activities.

Competitive landscape analysis emphasizing technological differentiation, supply-chain robustness, regulatory strategy, intellectual property positioning, and service-oriented commercialization models

Competitive dynamics in the capsule endoscopy ecosystem reflect a mix of established medtech firms, specialized imaging startups, and component suppliers that together shape innovation velocity and commercial reach. Leading technology providers are differentiating through investments in higher-definition optics, on-board analytics, and multimodal sensing capabilities that address both lesion detection and physiologic assessment. At the same time, strategic collaborations with clinical research centers and health systems underpin evidence generation efforts that inform guideline adoption and influence payer coverage decisions.

Manufacturers are pursuing varied product architectures to capture distinct purchaser preferences, from durable reusable platforms that support refurbishment programs to single-use and biodegradable designs that appeal to infection control and environmental objectives. Supply-chain integration and quality management practices remain competitive differentiators, particularly in the wake of tariff-driven sourcing realignments and increased scrutiny on component provenance.

Intellectual property strategies and regulatory milestones also demarcate competitive advantage: companies that secure robust patent portfolios around imaging algorithms, sensor integration, and form-factor innovations can create barriers to entry, while those that streamline regulatory submissions and post-market data collection reduce time-to-reimbursement. In parallel, commercialization models increasingly emphasize service-oriented offerings, such as packaged analytics subscriptions and clinician training programs, which deepen customer engagement and create recurring revenue opportunities.

Actionable strategic initiatives that integrate evidence generation, supply-chain fortification, tailored commercialization, and partnership models to accelerate clinical adoption and device resilience

Industry leaders should prioritize a cohesive strategy that aligns product innovation with clinical utility, operational feasibility, and regulatory preparedness. First, direct investments in clinical evidence that compare capsule-based diagnostics against standard-of-care procedures will clarify use-case boundaries and support payer conversations. Concurrently, manufacturers should refine product roadmaps to integrate multimodal sensing and intelligent pre-screening algorithms that reduce clinician review time and enhance diagnostic yield.

Second, supply-chain diversification and nearshoring for critical components will mitigate tariff exposure and enhance resilience; this should be paired with rigorous supplier qualification and harmonized quality systems to maintain regulatory compliance. Third, commercial strategies must be tailored to end-user needs: develop deployment models that address the specific workflow requirements of ambulatory surgical centers, clinics, and hospitals, and offer flexible purchasing and servicing options such as refurbishment programs and biodegradable single-use alternatives.

Finally, pursue strategic partnerships with clinical networks to accelerate real-world evidence collection, and adopt modular pricing and service bundles to lower adoption friction. By executing these actions in parallel, industry players can reduce operational risk, accelerate clinical acceptance, and create differentiated value propositions that resonate across diverse healthcare settings.

Robust mixed-method research methodology combining expert interviews, regulatory and technical validation, and iterative triangulation to ensure credible and actionable insights

The research underpinning this analysis synthesized primary qualitative interviews with clinicians, procurement leaders, regulatory specialists, and industry executives, complemented by systematic secondary research into device specifications, regulatory guidelines, and peer-reviewed clinical literature. Primary inputs were gathered through structured interviews and advisory panels to obtain frontline perspectives on clinical workflows, device performance expectations, and procurement drivers.

Secondary efforts involved cross-validation of technical specifications, patent filings, and regulatory submissions to triangulate product capabilities and market positioning. Data synthesis emphasized thematic convergence and divergence across clinical applications, end-user settings, technology platforms, product types, and sensor features. Where disagreements emerged, corroborative evidence from multiple stakeholders and document sources was used to resolve ambiguities and refine interpretation.

Limitations include the inherently dynamic nature of regulatory decisions and procurement policies, which can shift with new clinical evidence or policy changes. To address this, the methodology incorporated sensitivity checks and scenario-based analysis of strategic implications rather than quantitative estimations. Rigorous quality controls and iterative validation with domain experts ensured the analysis remained grounded, actionable, and relevant to commercial and clinical decision-makers.

Synthesis of technological progress, operational priorities, and policy impacts that together define strategic imperatives for converting innovation into clinical utility

Capsule gastrointestinal endoscopic devices occupy a pivotal role in modern diagnostic pathways by offering minimally invasive access to mucosal surfaces and physiological metrics across the alimentary tract. Technological advances in imaging, sensor integration, and connectivity are broadening clinical utility, while operational considerations and regional dynamics shape how devices are adopted in practice. The interplay between reusable and single-use product philosophies, tethered versus wireless architectures, and differentiated feature sets creates a diverse competitive environment that rewards clinical evidence, supply-chain resilience, and adaptable commercialization models.

The cumulative effect of recent policy and trade developments has underscored the importance of manufacturing flexibility and supplier diversification. At the same time, clinicians and payers increasingly expect robust comparative evidence and streamlined workflows that minimize clinician burden and support higher diagnostic confidence. As stakeholders align product capabilities with the distinct needs of colon, esophageal, and small intestine applications and tailor strategies to the unique demands of ambulatory centers, clinics, and hospitals, the pathway to broader clinical integration becomes clearer. In sum, coordinated action across R&D, regulatory, supply-chain, and commercial functions will determine which organizations translate technical promise into meaningful clinical impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Capsule Gastrointestinal Endoscopic Devices Market, by Technology

  • 8.1. Tethered
    • 8.1.1. Fiber Optic
    • 8.1.2. Wired Link
  • 8.2. Wireless
    • 8.2.1. Bluetooth
    • 8.2.2. Radio Frequency

9. Capsule Gastrointestinal Endoscopic Devices Market, by Product

  • 9.1. Reusable
    • 9.1.1. Multiuse Capsule
    • 9.1.2. Refurbished Capsule
  • 9.2. Single Use
    • 9.2.1. Biodegradable Capsule
    • 9.2.2. Plastic Capsule

10. Capsule Gastrointestinal Endoscopic Devices Market, by Feature

  • 10.1. Imaging Only
    • 10.1.1. High Definition
    • 10.1.2. Standard Definition
  • 10.2. Ph Sensor
    • 10.2.1. Extended Release
    • 10.2.2. Standard Ph
  • 10.3. Pressure Sensor
    • 10.3.1. Multi-Channel
    • 10.3.2. Single-Channel

11. Capsule Gastrointestinal Endoscopic Devices Market, by Application

  • 11.1. Colon
    • 11.1.1. Colon Polyps
    • 11.1.2. Colorectal Cancer Screening
  • 11.2. Esophagus
    • 11.2.1. Barrett's Esophagus
    • 11.2.2. Gastroesophageal Reflux Disease
  • 11.3. Small Intestine
    • 11.3.1. Celiac Disease
    • 11.3.2. Crohn's Disease
    • 11.3.3. Obscure Gastrointestinal Bleeding

12. Capsule Gastrointestinal Endoscopic Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals

13. Capsule Gastrointestinal Endoscopic Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Capsule Gastrointestinal Endoscopic Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Capsule Gastrointestinal Endoscopic Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Capsule Gastrointestinal Endoscopic Devices Market

17. China Capsule Gastrointestinal Endoscopic Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AnX Robotica Ltd.
  • 18.6. Beijing Richen-Force Technology Co., Ltd.
  • 18.7. Boston Scientific Corporation
  • 18.8. CapsoVision, Inc.
  • 18.9. Chongqing Aohua Photoelectricity Endoscope Co., Ltd.
  • 18.10. Chongqing Jinshan Science & Technology Co., Ltd.
  • 18.11. Given Imaging Ltd.
  • 18.12. IntroMedic Co., Ltd.
  • 18.13. Medtronic plc
  • 18.14. Micro-Tech (Nanjing) Co., Ltd.
  • 18.15. Nanjing Micro-Invasive Medical Inc.
  • 18.16. Pentax Medical
  • 18.17. Shanghai ANKON Medical Technologies Co., Ltd.
  • 18.18. Shanghai United Imaging Healthcare Co., Ltd.
  • 18.19. Shangxian Minimal Invasive Inc.
  • 18.20. Shenzhen Anke High-tech Co., Ltd.
  • 18.21. Shenzhen Capsule Medical Technology Co., Ltd.
  • 18.22. Shenzhen Chongqing Science & Technology Co., Ltd.
  • 18.23. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 18.24. Smart Medical Systems Ltd.
  • 18.25. SynMed Medical Technology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FEATURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FIBER OPTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FIBER OPTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FIBER OPTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRED LINK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRED LINK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRED LINK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY BLUETOOTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY BLUETOOTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY BLUETOOTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY RADIO FREQUENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY RADIO FREQUENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY RADIO FREQUENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY MULTIUSE CAPSULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY MULTIUSE CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY MULTIUSE CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REFURBISHED CAPSULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REFURBISHED CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REFURBISHED CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY BIODEGRADABLE CAPSULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY BIODEGRADABLE CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY BIODEGRADABLE CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PLASTIC CAPSULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PLASTIC CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PLASTIC CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FEATURE, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HIGH DEFINITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HIGH DEFINITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HIGH DEFINITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STANDARD DEFINITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STANDARD DEFINITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STANDARD DEFINITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY EXTENDED RELEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY EXTENDED RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STANDARD PH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STANDARD PH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STANDARD PH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY MULTI-CHANNEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY MULTI-CHANNEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY MULTI-CHANNEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE-CHANNEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE-CHANNEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE-CHANNEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON POLYPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON POLYPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON POLYPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLORECTAL CANCER SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLORECTAL CANCER SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLORECTAL CANCER SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY BARRETT'S ESOPHAGUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY BARRETT'S ESOPHAGUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY BARRETT'S ESOPHAGUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY CELIAC DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY CELIAC DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY CELIAC DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY CROHN'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY CROHN'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY CROHN'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY OBSCURE GASTROINTESTINAL BLEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY OBSCURE GASTROINTESTINAL BLEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY OBSCURE GASTROINTESTINAL BLEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FEATURE, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FEATURE, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FEATURE, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FEATURE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FEATURE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FEATURE, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FEATURE, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FEATURE, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FEATURE, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. GCC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 266. GCC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. GCC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, 2018-2032 (USD MILLION)
  • TABLE 268. GCC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 269. GCC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION